Almac Discovery | Cutting-edge Oncology Research
Almac Discovery is a research driven, oncology business unit within the Almac Group, dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programmes with the pharmaceutical industry at the discovery to preclinical stage (view our pipeline).
Key Research Areas
Almac Discovery specialise in Ubiquitin Specific Proteases (USPs)Read more
Discovery News & Events
Stay up to date with all the latest news and events at Almac Discovery.Read more